Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy for AIDS-related Kaposi's sarcoma
NCT00002167Phase 2Completed
- Sponsor
- Clinical Solutions Group
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of Rostaporfin in Kaposi's sarcoma (KS), sponsored by Clinical Solutions Group. Status: completed.
02
Drugs
Rostaporfin
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00002167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002167.